Sex;Age group;Size of municipality of residence;Perception of risk of infection of HIV/AIDS by injectable drugs;Total
Both sexes;Total;Total;Total;20,759.6
Both sexes;Total;Total;High risk;12,112.0
Both sexes;Total;Total;Intermediate risk;2,041.3
Both sexes;Total;Total;Low or no risk;96.7
Both sexes;Total;Total;Depends on whether they share syringes or not;6,244.5
Both sexes;Total;Total;No data recorded;265.2
Both sexes;Total;Up to 10000 inhabitants;Total;4,666.4
Both sexes;Total;Up to 10000 inhabitants;High risk;2,728.7
Both sexes;Total;Up to 10000 inhabitants;Intermediate risk;467.1
Both sexes;Total;Up to 10000 inhabitants;Low or no risk;29.8
Both sexes;Total;Up to 10000 inhabitants;Depends on whether they share syringes or not;1,381.8
Both sexes;Total;Up to 10000 inhabitants;No data recorded;59.1
Both sexes;Total;From 10001 to 50000 inhabitants;Total;5,138.6
Both sexes;Total;From 10001 to 50000 inhabitants;High risk;2,985.9
Both sexes;Total;From 10001 to 50000 inhabitants;Intermediate risk;497.2
Both sexes;Total;From 10001 to 50000 inhabitants;Low or no risk;17.9
Both sexes;Total;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;1,572.9
Both sexes;Total;From 10001 to 50000 inhabitants;No data recorded;64.7
Both sexes;Total;From 50001 to 500000 inhabitants;Total;7,305.1
Both sexes;Total;From 50001 to 500000 inhabitants;High risk;4,308.2
Both sexes;Total;From 50001 to 500000 inhabitants;Intermediate risk;729.2
Both sexes;Total;From 50001 to 500000 inhabitants;Low or no risk;35.1
Both sexes;Total;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;2,158.7
Both sexes;Total;From 50001 to 500000 inhabitants;No data recorded;73.8
Both sexes;Total;More than 500000 inhabitants;Total;3,649.5
Both sexes;Total;More than 500000 inhabitants;High risk;2,089.1
Both sexes;Total;More than 500000 inhabitants;Intermediate risk;347.8
Both sexes;Total;More than 500000 inhabitants;Low or no risk;13.9
Both sexes;Total;More than 500000 inhabitants;Depends on whether they share syringes or not;1,131.2
Both sexes;Total;More than 500000 inhabitants;No data recorded;67.5
Both sexes;From 18 to 29 years of age;Total;Total;7,679.9
Both sexes;From 18 to 29 years of age;Total;High risk;4,493.7
Both sexes;From 18 to 29 years of age;Total;Intermediate risk;840.6
Both sexes;From 18 to 29 years of age;Total;Low or no risk;38.1
Both sexes;From 18 to 29 years of age;Total;Depends on whether they share syringes or not;2,220.2
Both sexes;From 18 to 29 years of age;Total;No data recorded;87.2
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;Total;1,625.0
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;High risk;948.8
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;Intermediate risk;157.9
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;Low or no risk;10.2
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;490.9
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;No data recorded;17.3
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Total;1,935.5
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;High risk;1,138.5
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Intermediate risk;210.4
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Low or no risk;3.6
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;561.4
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;No data recorded;21.7
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Total;2,784.1
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;High risk;1,649.1
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Intermediate risk;316.6
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Low or no risk;16.6
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;770.6
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;No data recorded;31.3
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;Total;1,335.2
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;High risk;757.4
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;Intermediate risk;155.8
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;Low or no risk;7.8
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;397.4
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;No data recorded;17.0
Both sexes;From 30 to 39 years of age;Total;Total;7,043.6
Both sexes;From 30 to 39 years of age;Total;High risk;3,965.1
Both sexes;From 30 to 39 years of age;Total;Intermediate risk;672.5
Both sexes;From 30 to 39 years of age;Total;Low or no risk;32.0
Both sexes;From 30 to 39 years of age;Total;Depends on whether they share syringes or not;2,279.7
Both sexes;From 30 to 39 years of age;Total;No data recorded;94.4
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;Total;1,627.7
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;High risk;926.6
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;Intermediate risk;166.4
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;Low or no risk;5.9
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;510.1
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;No data recorded;18.7
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Total;1,762.7
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;High risk;974.6
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Intermediate risk;160.0
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Low or no risk;8.1
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;595.1
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;No data recorded;25.0
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Total;2,394.3
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;High risk;1,355.6
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Intermediate risk;236.0
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Low or no risk;15.0
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;764.7
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;No data recorded;23.0
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;Total;1,258.9
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;High risk;708.4
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;Intermediate risk;110.1
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;Low or no risk;2.9
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;409.8
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;No data recorded;27.7
Both sexes;From 40 to 49 years of age;Total;Total;6,036.1
Both sexes;From 40 to 49 years of age;Total;High risk;3,653.2
Both sexes;From 40 to 49 years of age;Total;Intermediate risk;528.2
Both sexes;From 40 to 49 years of age;Total;Low or no risk;26.7
Both sexes;From 40 to 49 years of age;Total;Depends on whether they share syringes or not;1,744.5
Both sexes;From 40 to 49 years of age;Total;No data recorded;83.6
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;Total;1,413.7
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;High risk;853.3
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;Intermediate risk;142.8
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;Low or no risk;13.7
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;380.8
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;No data recorded;23.2
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Total;1,440.3
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;High risk;872.9
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Intermediate risk;126.9
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Low or no risk;6.2
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;416.3
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;No data recorded;18.0
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Total;2,126.7
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;High risk;1,303.6
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Intermediate risk;176.6
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Low or no risk;3.6
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;623.3
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;No data recorded;19.6
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;Total;1,055.4
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;High risk;623.4
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;Intermediate risk;81.9
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;Low or no risk;3.2
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;324.1
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;No data recorded;22.8
Males;Total;Total;Total;10,532.1
Males;Total;Total;High risk;6,158.8
Males;Total;Total;Intermediate risk;1,216.2
Males;Total;Total;Low or no risk;70.6
Males;Total;Total;Depends on whether they share syringes or not;2,939.4
Males;Total;Total;No data recorded;147.1
Males;Total;Up to 10000 inhabitants;Total;2,407.7
Males;Total;Up to 10000 inhabitants;High risk;1,401.2
Males;Total;Up to 10000 inhabitants;Intermediate risk;281.7
Males;Total;Up to 10000 inhabitants;Low or no risk;19.3
Males;Total;Up to 10000 inhabitants;Depends on whether they share syringes or not;664.3
Males;Total;Up to 10000 inhabitants;No data recorded;41.1
Males;Total;From 10001 to 50000 inhabitants;Total;2,651.3
Males;Total;From 10001 to 50000 inhabitants;High risk;1,529.5
Males;Total;From 10001 to 50000 inhabitants;Intermediate risk;319.6
Males;Total;From 10001 to 50000 inhabitants;Low or no risk;14.2
Males;Total;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;756.4
Males;Total;From 10001 to 50000 inhabitants;No data recorded;31.7
Males;Total;From 50001 to 500000 inhabitants;Total;3,716.4
Males;Total;From 50001 to 500000 inhabitants;High risk;2,250.3
Males;Total;From 50001 to 500000 inhabitants;Intermediate risk;429.7
Males;Total;From 50001 to 500000 inhabitants;Low or no risk;23.2
Males;Total;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;971.5
Males;Total;From 50001 to 500000 inhabitants;No data recorded;41.6
Males;Total;More than 500000 inhabitants;Total;1,756.8
Males;Total;More than 500000 inhabitants;High risk;977.8
Males;Total;More than 500000 inhabitants;Intermediate risk;185.2
Males;Total;More than 500000 inhabitants;Low or no risk;13.9
Males;Total;More than 500000 inhabitants;Depends on whether they share syringes or not;547.2
Males;Total;More than 500000 inhabitants;No data recorded;32.7
Males;From 18 to 29 years of age;Total;Total;3,932.5
Males;From 18 to 29 years of age;Total;High risk;2,290.8
Males;From 18 to 29 years of age;Total;Intermediate risk;487.0
Males;From 18 to 29 years of age;Total;Low or no risk;30.7
Males;From 18 to 29 years of age;Total;Depends on whether they share syringes or not;1,072.4
Males;From 18 to 29 years of age;Total;No data recorded;51.6
Males;From 18 to 29 years of age;Up to 10000 inhabitants;Total;782.3
Males;From 18 to 29 years of age;Up to 10000 inhabitants;High risk;431.2
Males;From 18 to 29 years of age;Up to 10000 inhabitants;Intermediate risk;95.0
Males;From 18 to 29 years of age;Up to 10000 inhabitants;Low or no risk;6.0
Males;From 18 to 29 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;238.5
Males;From 18 to 29 years of age;Up to 10000 inhabitants;No data recorded;11.7
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Total;1,046.6
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;High risk;613.1
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Intermediate risk;136.0
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Low or no risk;2.9
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;280.6
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;No data recorded;14.1
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Total;1,436.6
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;High risk;883.0
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Intermediate risk;174.7
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Low or no risk;14.0
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;349.6
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;No data recorded;15.2
Males;From 18 to 29 years of age;More than 500000 inhabitants;Total;666.9
Males;From 18 to 29 years of age;More than 500000 inhabitants;High risk;363.5
Males;From 18 to 29 years of age;More than 500000 inhabitants;Intermediate risk;81.3
Males;From 18 to 29 years of age;More than 500000 inhabitants;Low or no risk;7.8
Males;From 18 to 29 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;203.7
Males;From 18 to 29 years of age;More than 500000 inhabitants;No data recorded;10.6
Males;From 30 to 39 years of age;Total;Total;3,584.4
Males;From 30 to 39 years of age;Total;High risk;2,043.8
Males;From 30 to 39 years of age;Total;Intermediate risk;396.3
Males;From 30 to 39 years of age;Total;Low or no risk;21.2
Males;From 30 to 39 years of age;Total;Depends on whether they share syringes or not;1,074.0
Males;From 30 to 39 years of age;Total;No data recorded;49.1
Males;From 30 to 39 years of age;Up to 10000 inhabitants;Total;849.0
Males;From 30 to 39 years of age;Up to 10000 inhabitants;High risk;485.6
Males;From 30 to 39 years of age;Up to 10000 inhabitants;Intermediate risk;98.6
Males;From 30 to 39 years of age;Up to 10000 inhabitants;Low or no risk;5.9
Males;From 30 to 39 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;249.9
Males;From 30 to 39 years of age;Up to 10000 inhabitants;No data recorded;9.0
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Total;906.3
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;High risk;506.0
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Intermediate risk;103.0
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Low or no risk;5.1
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;279.6
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;No data recorded;12.6
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Total;1,243.0
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;High risk;728.4
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Intermediate risk;140.4
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Low or no risk;7.2
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;353.9
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;No data recorded;13.1
Males;From 30 to 39 years of age;More than 500000 inhabitants;Total;586.2
Males;From 30 to 39 years of age;More than 500000 inhabitants;High risk;323.8
Males;From 30 to 39 years of age;More than 500000 inhabitants;Intermediate risk;54.3
Males;From 30 to 39 years of age;More than 500000 inhabitants;Low or no risk;2.9
Males;From 30 to 39 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;190.6
Males;From 30 to 39 years of age;More than 500000 inhabitants;No data recorded;14.4
Males;From 40 to 49 years of age;Total;Total;3,015.2
Males;From 40 to 49 years of age;Total;High risk;1,824.2
Males;From 40 to 49 years of age;Total;Intermediate risk;332.9
Males;From 40 to 49 years of age;Total;Low or no risk;18.7
Males;From 40 to 49 years of age;Total;Depends on whether they share syringes or not;793.0
Males;From 40 to 49 years of age;Total;No data recorded;46.4
Males;From 40 to 49 years of age;Up to 10000 inhabitants;Total;776.3
Males;From 40 to 49 years of age;Up to 10000 inhabitants;High risk;484.4
Males;From 40 to 49 years of age;Up to 10000 inhabitants;Intermediate risk;88.2
Males;From 40 to 49 years of age;Up to 10000 inhabitants;Low or no risk;7.3
Males;From 40 to 49 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;175.9
Males;From 40 to 49 years of age;Up to 10000 inhabitants;No data recorded;20.5
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Total;698.4
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;High risk;410.4
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Intermediate risk;80.6
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Low or no risk;6.2
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;196.2
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;No data recorded;5.0
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Total;1,036.7
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;High risk;639.0
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Intermediate risk;114.6
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Low or no risk;1.9
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;268.0
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;No data recorded;13.3
Males;From 40 to 49 years of age;More than 500000 inhabitants;Total;503.7
Males;From 40 to 49 years of age;More than 500000 inhabitants;High risk;290.4
Males;From 40 to 49 years of age;More than 500000 inhabitants;Intermediate risk;49.5
Males;From 40 to 49 years of age;More than 500000 inhabitants;Low or no risk;3.2
Males;From 40 to 49 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;152.9
Males;From 40 to 49 years of age;More than 500000 inhabitants;No data recorded;7.6
Females;Total;Total;Total;10,227.5
Females;Total;Total;High risk;5,953.2
Females;Total;Total;Intermediate risk;825.0
Females;Total;Total;Low or no risk;26.2
Females;Total;Total;Depends on whether they share syringes or not;3,305.0
Females;Total;Total;No data recorded;118.1
Females;Total;Up to 10000 inhabitants;Total;2,258.7
Females;Total;Up to 10000 inhabitants;High risk;1,327.5
Females;Total;Up to 10000 inhabitants;Intermediate risk;185.3
Females;Total;Up to 10000 inhabitants;Low or no risk;10.5
Females;Total;Up to 10000 inhabitants;Depends on whether they share syringes or not;717.4
Females;Total;Up to 10000 inhabitants;No data recorded;18.0
Females;Total;From 10001 to 50000 inhabitants;Total;2,487.3
Females;Total;From 10001 to 50000 inhabitants;High risk;1,456.4
Females;Total;From 10001 to 50000 inhabitants;Intermediate risk;177.6
Females;Total;From 10001 to 50000 inhabitants;Low or no risk;3.7
Females;Total;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;816.5
Females;Total;From 10001 to 50000 inhabitants;No data recorded;33.0
Females;Total;From 50001 to 500000 inhabitants;Total;3,588.7
Females;Total;From 50001 to 500000 inhabitants;High risk;2,057.9
Females;Total;From 50001 to 500000 inhabitants;Intermediate risk;299.5
Females;Total;From 50001 to 500000 inhabitants;Low or no risk;12.0
Females;Total;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;1,187.1
Females;Total;From 50001 to 500000 inhabitants;No data recorded;32.3
Females;Total;More than 500000 inhabitants;Total;1,892.7
Females;Total;More than 500000 inhabitants;High risk;1,111.4
Females;Total;More than 500000 inhabitants;Intermediate risk;162.6
Females;Total;More than 500000 inhabitants;Low or no risk;0.0
Females;Total;More than 500000 inhabitants;Depends on whether they share syringes or not;583.9
Females;Total;More than 500000 inhabitants;No data recorded;34.8
Females;From 18 to 29 years of age;Total;Total;3,747.4
Females;From 18 to 29 years of age;Total;High risk;2,203.0
Females;From 18 to 29 years of age;Total;Intermediate risk;353.6
Females;From 18 to 29 years of age;Total;Low or no risk;7.4
Females;From 18 to 29 years of age;Total;Depends on whether they share syringes or not;1,147.8
Females;From 18 to 29 years of age;Total;No data recorded;35.6
Females;From 18 to 29 years of age;Up to 10000 inhabitants;Total;842.7
Females;From 18 to 29 years of age;Up to 10000 inhabitants;High risk;517.6
Females;From 18 to 29 years of age;Up to 10000 inhabitants;Intermediate risk;62.9
Females;From 18 to 29 years of age;Up to 10000 inhabitants;Low or no risk;4.2
Females;From 18 to 29 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;252.4
Females;From 18 to 29 years of age;Up to 10000 inhabitants;No data recorded;5.6
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Total;888.9
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;High risk;525.4
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Intermediate risk;74.4
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.7
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;280.8
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;No data recorded;7.6
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Total;1,347.5
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;High risk;766.1
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Intermediate risk;141.9
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Low or no risk;2.5
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;421.0
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;No data recorded;16.0
Females;From 18 to 29 years of age;More than 500000 inhabitants;Total;668.3
Females;From 18 to 29 years of age;More than 500000 inhabitants;High risk;393.9
Females;From 18 to 29 years of age;More than 500000 inhabitants;Intermediate risk;74.4
Females;From 18 to 29 years of age;More than 500000 inhabitants;Low or no risk;0.0
Females;From 18 to 29 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;193.6
Females;From 18 to 29 years of age;More than 500000 inhabitants;No data recorded;6.4
Females;From 30 to 39 years of age;Total;Total;3,459.2
Females;From 30 to 39 years of age;Total;High risk;1,921.3
Females;From 30 to 39 years of age;Total;Intermediate risk;276.1
Females;From 30 to 39 years of age;Total;Low or no risk;10.8
Females;From 30 to 39 years of age;Total;Depends on whether they share syringes or not;1,205.7
Females;From 30 to 39 years of age;Total;No data recorded;45.3
Females;From 30 to 39 years of age;Up to 10000 inhabitants;Total;778.7
Females;From 30 to 39 years of age;Up to 10000 inhabitants;High risk;441.0
Females;From 30 to 39 years of age;Up to 10000 inhabitants;Intermediate risk;67.8
Females;From 30 to 39 years of age;Up to 10000 inhabitants;Low or no risk;0.0
Females;From 30 to 39 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;260.2
Females;From 30 to 39 years of age;Up to 10000 inhabitants;No data recorded;9.7
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Total;856.5
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;High risk;468.5
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Intermediate risk;57.0
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Low or no risk;3.0
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;315.5
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;No data recorded;12.4
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Total;1,151.2
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;High risk;627.2
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Intermediate risk;95.6
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Low or no risk;7.8
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;410.8
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;No data recorded;9.9
Females;From 30 to 39 years of age;More than 500000 inhabitants;Total;672.8
Females;From 30 to 39 years of age;More than 500000 inhabitants;High risk;384.5
Females;From 30 to 39 years of age;More than 500000 inhabitants;Intermediate risk;55.8
Females;From 30 to 39 years of age;More than 500000 inhabitants;Low or no risk;0.0
Females;From 30 to 39 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;219.1
Females;From 30 to 39 years of age;More than 500000 inhabitants;No data recorded;13.3
Females;From 40 to 49 years of age;Total;Total;3,020.9
Females;From 40 to 49 years of age;Total;High risk;1,828.9
Females;From 40 to 49 years of age;Total;Intermediate risk;195.3
Females;From 40 to 49 years of age;Total;Low or no risk;8.0
Females;From 40 to 49 years of age;Total;Depends on whether they share syringes or not;951.5
Females;From 40 to 49 years of age;Total;No data recorded;37.2
Females;From 40 to 49 years of age;Up to 10000 inhabitants;Total;637.3
Females;From 40 to 49 years of age;Up to 10000 inhabitants;High risk;368.9
Females;From 40 to 49 years of age;Up to 10000 inhabitants;Intermediate risk;54.6
Females;From 40 to 49 years of age;Up to 10000 inhabitants;Low or no risk;6.3
Females;From 40 to 49 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;204.9
Females;From 40 to 49 years of age;Up to 10000 inhabitants;No data recorded;2.7
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Total;741.9
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;High risk;462.5
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Intermediate risk;46.3
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.0
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;220.1
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;No data recorded;13.0
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Total;1,090.0
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;High risk;664.6
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Intermediate risk;62.0
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Low or no risk;1.7
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;355.3
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;No data recorded;6.3
Females;From 40 to 49 years of age;More than 500000 inhabitants;Total;551.7
Females;From 40 to 49 years of age;More than 500000 inhabitants;High risk;333.0
Females;From 40 to 49 years of age;More than 500000 inhabitants;Intermediate risk;32.4
Females;From 40 to 49 years of age;More than 500000 inhabitants;Low or no risk;0.0
Females;From 40 to 49 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;171.2
Females;From 40 to 49 years of age;More than 500000 inhabitants;No data recorded;15.1